Arkolith/Insider Trading/GCTK/Form 4

Ballantyne John

Director, 10% OwnerGlucotrack, Inc. (GCTK) · full profile →Form 4 · filed Mar 31, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
3 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 26, 2025Grant(A)4K—$04K
Mar 12, 2025Option exercise(X)2.6M—$02.7M
Nov 14, 2024Other(J)132K$31.00$4.1M183K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 12, 2025Option exercise(X)132K—$00
Nov 14, 2024Grant(A)132K——132K
Nov 14, 2024Grant(A)132K——132K
Jul 30, 2024Buy(P)59K——59K
Jul 30, 2024Buy(P)76K——76K
Jul 30, 2024Buy(P)107K——107K

Transaction Codes

A
Grant / award
X
Exercise of in-the-money derivative
J
Other acquisition / disposition
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001474506-25-000072) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML